A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/30/2011	CN101085058B 一种含有赤芍和麝香的药物组合物、制备方法和制剂 A pharmaceutical composition containing a red peony and musk, preparation methods and formulations
11/30/2011	CN101085026B 一种含有丹参和麝香的药物组合物、制备方法和制剂 The pharmaceutical compositions containing salvia and musk, preparation methods and formulations
11/30/2011	CN101085001B 一种含丹参素的复方丹参冻干粉针剂及其制备方法 Danshensu compound containing freeze-dried powder of salvia and its preparation method
11/29/2011	US8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma
11/29/2011	US8067451 Oral dosage form comprising therapeutically effective dosage of ibuprofen and famotidine is administered three times per day; side effect reduction; antiulcer agents
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011	US8067346 Phosphorus and sulfur free; friction reduction; safe for catalytic converters; environmentally friendly; engine lifetime
11/29/2011	US8067043 Herbal composition for treatment of hyperlipidemia and the inhibition of myocardial infarction
11/29/2011	US8067033 Stable compositions of famotidine and ibuprofen
11/29/2011	US8067032 Method for preparing submicron particles of antineoplastic agents
11/29/2011	US8067031 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067029 Rapidly disintegrating gelatinous coated tablets
11/29/2011	US8067028 Drug delivery device
11/29/2011	US8067024 Medical devices to prevent or inhibit restenosis
11/29/2011	US8067022 Therapeutic inhibitor of vascular smooth muscle cells
11/29/2011	US8067020 Sustained release formulation
11/29/2011	US8067017 Preservation of bioactive materials by freeze dried foam
11/29/2011	US8066976 Foaming compositions for hair care
11/29/2011	US8066975 Psoriasis or seborrheic dermatitis; mixture of clobetasol propionate, an anionic surfactant (sodium lauryl ether sulfate), an amphoteric surfactant ( cocamidopropyl betaines); a propenetrating agent chosen from ethanol, isopropanol, propylene glycol and ethoxydiglycol; foam with good compactnes; shampoo
11/29/2011	US8066918 Apparatus for producing particles, emulsifier holding member, method for producing particles, and method for producing molecular membrane
11/29/2011	US8066904 Controlled generation of nitric oxide
11/29/2011	US8066695 Implantable apparatus for administering a therapeutic agent into tissue
11/29/2011	US8066694 Homeostatic insulin pump
11/29/2011	US8066120 Sachet constructions
11/29/2011	US8066117 Preparation-at-use device comprising pre-formed hydrogel product
11/29/2011	CA2641581C Stabilization of solid thyroid drug formulations
11/29/2011	CA2638985C Therapeutic agent containing .omega.-feline interferon for treating feline atopic dermatitis
11/29/2011	CA2626531C Sodium chloride solution for drug reconstitution or dilution
11/29/2011	CA2621066C Method for treatment or prevention of conditions caused by gram-positive bacteria
11/29/2011	CA2614647C Osmotic device containing venlafaxine and an anti-psychotic agent
11/29/2011	CA2613417C Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
11/29/2011	CA2611520C Method and composition for pharmaceutical product
11/29/2011	CA2535364C Hyaluronic acid nanoparticles
11/29/2011	CA2513483C Injectable hydrogel microspheres from aqueous two-phase system
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2479711C Formulation
11/29/2011	CA2462580C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)
11/29/2011	CA2461970C Microdevice and method of delivering or withdrawing a substance through the skin of an animal
11/29/2011	CA2461349C Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
11/29/2011	CA2456327C Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/29/2011	CA2449356C Process for preparing granular compositions
11/29/2011	CA2423227C Reduced-viscosity concentrated protein formulations
11/28/2011	CA2740537A1 Rapamycin coated expandable devices
11/28/2011	CA2706292A1 A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide
11/27/2011	CA2741179A1 Hydrogel implants with varying degrees of crosslinking
11/27/2011	CA2741142A1 Hydrogel implants with varying degrees of crosslinking
11/27/2011	CA2737706A1 Biodegradable polymer encapsulated microsphere particulate film and method of making thereof
11/27/2011	CA2705685A1 Pharmaceutical dosage form containing an antipsychotic agent
11/24/2011	WO2011146876A2 Oral transmucosal administration of sufentanil
11/24/2011	WO2011146858A2 Foams, including microcellular foams, containing colloidal particulates
11/24/2011	WO2011146852A2 Foam or particles for applications such as drug delivery
11/24/2011	WO2011146808A2 Topical formulation for a jak inhibitor
11/24/2011	WO2011146801A1 Formulation and dosing of hsp90 inhibitory compounds
11/24/2011	WO2011146611A1 Modified gastroretentive drug delivery system for amine drugs
11/24/2011	WO2011146583A2 Nanoparticulate cinacalcet formulations
11/24/2011	WO2011146516A1 Combination therapy for ovarian cancer
11/24/2011	WO2011146078A1 Encapsulated particles for enteric release
11/24/2011	WO2011146077A1 Encapsulated particles for amorphous stability enhancement
11/24/2011	WO2011146032A2 Effervescent formulations
11/24/2011	WO2011146030A2 Effervescent antihistamine formulations
11/24/2011	WO2011145993A1 Treatment for reducing inflammation
11/24/2011	WO2011145963A1 Non-leaching nanoparticle formulation for the intracellular delivery of hydrophobic drugs and its use to modulate cell activity and differentiation
11/24/2011	WO2011145745A1 Vesicles with encapsulated substance and production method therefor
11/24/2011	WO2011145660A1 Propofol-containing oil-in-water emulsion composition
11/24/2011	WO2011145659A1 Carotenoid-containing composition and production method therefor
11/24/2011	WO2011145642A1 Pharmaceutical composition containing solifenacin
11/24/2011	WO2011145109A1 Dry powder inhalation composition
11/24/2011	WO2011144994A1 Pharmaceutical compositions of nsaid and acid inhibitor
11/24/2011	WO2011144975A1 Multi-unit compositions
11/24/2011	WO2011144916A1 Hemostatic compositions
11/24/2011	WO2011144777A1 Combination of n-acetylcysteine and lipoic acid for the treatment of a disease with axonal damage and concomitant oxidative lesions
11/24/2011	WO2011144766A1 Pharmaceutical composition of ibuprofen for injection
11/24/2011	WO2011144748A1 Process for the production of a nanomaterial and reactor for implementing it
11/24/2011	WO2011144746A2 Liquid nasal spray containing low-dose naltrexone
11/24/2011	WO2011144745A2 Improved liposomal formulations of lipophilic compounds
11/24/2011	WO2011144731A1 Nanoporous foamed, active ingredient-containing preparations on the basis of pharmaceutically acceptable thermoplastically processable polymers
11/24/2011	WO2011144727A1 Preparations of biologically active substances with enlarged surface area based on amphiphilic copolymers
11/24/2011	WO2011144724A1 A pharmaceutical controlled release composition of losartan
11/24/2011	WO2011144677A1 Pharmaceutical composition of ibuprofen for injection
11/24/2011	WO2011144673A2 Long - acting formulations of insulins
11/24/2011	WO2011144650A1 Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
11/24/2011	WO2011144335A1 Stable ready to use injectable paracetamol formulation
11/24/2011	WO2011144327A1 Posology and administration of glucocorticoid based compositions
11/24/2011	WO2011144248A1 Composition for removing atheromatous plaque
11/24/2011	WO2011143953A1 Method and apparatus for manufacturing microspheres
11/24/2011	WO2011143844A1 Traditional chinese medicine composition for treating infection of influenza a virus subtype and preparation method thereof
11/24/2011	WO2011143843A1 Atomizing formulation comprising plant extract and its preparation method
11/24/2011	WO2011121305A3 Method for preserving alum adjuvants and alum-adjuvanted vaccines
11/24/2011	WO2011112229A3 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
11/24/2011	WO2011107525A3 Activatable drug dispensing system
11/24/2011	WO2011101833A3 Slow release liquid drug delivery device
11/24/2011	WO2011100668A4 Methods and compositions of civamide to treat diseases of the intestines
11/24/2011	WO2011088333A3 Solid-forming local anesthetic formulations for pain control
11/24/2011	WO2011087494A3 Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
11/24/2011	WO2011085155A3 Formulations and methods for dissolving cerumen
11/24/2011	WO2011084513A3 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
11/24/2011	WO2011079239A3 Combination tablet with chewable outer layer
11/24/2011	WO2011076841A3 Combination therapy for copd

1 ... 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 ... 2991